This brand name is authorized in France, Ireland, New Zealand, Romania, United Kingdom
The drug ULTRAPROCT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Fluocortolone pivalate
UNII 9J8AL6K50Q - FLUOCORTOLONE PIVALATE
|
|
Fluocortolone pivalate inhibits inflammatory and allergic skin reactions, and alleviates subjective complaints such as pruritus, smarting, and pain. The substance reduces dilatation of the capillaries, oedema of the interstitial cells and infiltration of the tissues. Capillary multiplication is inhibited. |
|
2
Fluocortolone caproate
UNII 90893P8662 - FLUOCORTOLONE CAPROATE
|
|
Fluocortolone pivalate inhibits inflammatory and allergic skin reactions, and alleviates subjective complaints such as pruritus, smarting, and pain. The substance reduces dilatation of the capillaries, oedema of the interstitial cells and infiltration of the tissues. Capillary multiplication is inhibited. |
|
3
Cinchocaine
UNII L6JW2TJG99 - DIBUCAINE
|
|
Cinchocaine is a local anaesthetic agent and is suitable for surface or spinal anaesthesia and for relaxing sphincteric spasms. It is an anaesthetic of the amide type. It is more toxic than cocaine by local application but its local anaesthetic action is greater so it can be used in lower concentrations. Its action is more prolonged than lignocaine. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 63394747, 68579162 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 21889, 21900 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 51039 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 785, 787 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67016001, W67016002, W67017001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
